<?xml version="1.0" encoding="UTF-8"?>
<p>Approximately 10% of people with chronic hepatitis C virus (HCV) infection globally are past or current illicit drug users [
 <xref rid="ref1" ref-type="bibr">1</xref>]. Sharing needles and syringes among people who inject drugs (PWID) is the main route of HCV transmission in developed countries. HCV infection poses an important health issue among PWID, while in many countries the burden of liver disease due to chronic hepatitis C in this population is expected to increase over the next decade [
 <xref rid="ref1" ref-type="bibr">1</xref>,
 <xref rid="ref2" ref-type="bibr">2</xref>]. Therefore, there is a need to prioritize PWID for scaling up HCV testing and treatment.
</p>
